Table 2 Demographics and audiologic features of patients in Group A and Group B.

From: The therapeutic effect of hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss

Characteristic

Group A

(Oral steroid + HBOT)

(n = 17)

Group B

(Oral steroid)

(n = 10)

p-value

Mean age (years)

51.0 ± 17.0

56.4 ± 18.5

0.477a

Gender (Male: Female)

11:6

5:5

0.687c

Side (Right: left)

10:7

7:3

0.692c

Time from symptom onset of SSNHL to treatment (days)

2.6 ± 2.1

2.3 ± 2.3

0.428b

Initial PTA (dB)

99.9 ± 11.4

101.9 ± 12.3

0.679a

 80–89 dB SSNHL

3 (17.6%)

2 (20.0%)

1.000c

 90–99 dB SSNHL

4 (23.5%)

2 (20.0%)

1.000c

  ≥ 100 dB SSNHL

10 (58.8%)

6 (60.0%)

1.000c

Rate of diabetes (n [%])

2 (11.7%)

0 (0.0%)

 
  1. Data are presented as mean ± standard error of the mean, or subject num.
  2. HBOT, Hyperbaric oxygen therapy; SSNHL, Sudden sensorineural hearing loss; PTA, Pure-tone average.
  3. ap-value were calculated by student-T test.
  4. bp-value were calculated by Mann–Whitney test.
  5. cp-value were calculated by Fisher’s exact test.
Back to article page